by MMAjunkie.com Staff on Jun 18, 2012 at 1:35 pm ET
Former Strikeforce light-heavyweight champion Rafael "Feijao" Cavalcante's recent failed drug test was due to stanozolol metabolites.
As MMAjunkie.com (www.mmajunkie.com) reported Saturday, the Brazilian fighterfailed a test following his May win over Mike Kyle. On Monday the California State Athletic Commisssion confirmed the substance.
The CSAC on Monday also said that in addition to Cavalcante's yearlong suspension and $2,500 fine, his win over Kyle will be overturned and changed to a no-contest.
The bout took place at "Strikeforce: Heavyweight Grand Prix Final," which took place May 19 at HP Pavilion in San Jose, Calif.
Stanozolol is a synthetic anabolic steroid that has commonly been used by athletes. MMA fighters who have tested positive for the banned substance include Cristiane "Cyborg" Santos, Tim Sylvia and Chris Leben.
MMAjunkie.com has learned Cavalcante's camp has filed an appeal with the CSAC and is awaiting a date for a hearing.
According to the CSAC, Cavalcante (12-3 MMA, 5-2 SF) was tested on May 18, the day before his fight. Cavalcante went through Kyle quickly on the Showtime-televised main card and submitted Kyle in just 33 seconds. The win was expected to put him in position to face Gegard Mousasi for the vacant 205-pound title later this year.
Cavalcante was suspended by the CSAC for a year, retroactive to the May 18 test date. He made a disclosed payday of $66,000 for the fight, which included a $33,000 win bonus.
"Our primary concern is for the health and safety of fighters," CSAC executive officer George Dodd stated. "Anabolic agents and other banned substances put not only the users of those agents at risk, but their opponents as well. The commission simply will not tolerate their use."